A follow-up analysis shows that the benefits of hormone therapy for the treatment of menopause symptoms outweigh the risks ...
Researchers examined 453 menopausal women aged 40–65 with moderate or severe hot flushes who were unsuitable for hormone replacement therapy, after giving them 45mg of fezolinetant or placebo ...
Researchers found un-immediate relatives – ie grandparents, aunts, uncles, nieces and nephews – were 1.5 times more likely to get colon cancer if their relative had started the menopause early ...
Moderate to severe hot flashes may triple the risk of metabolic dysfunction steatotic liver disease, a study suggests.
Research, by her menopause clinic Newson Health, found almost a third of women had between two and five medical appointments before their symptoms were diagnosed as linked to the perimenopause and ...
If exercise seems to trigger hot flashes, switching to lower-intensity activities could help reduce hot flash frequency.
Transgender men suffer from 'postmenopausal bladder and bowel symptoms because of taking testosterone, a study has found. Researchers found that of the 68 transgender men who participated in the ...
A new study published in the JAMA said that hormonal therapy can help to ease the symptoms of menopause. The study also found ...
Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of ...
Women are being forced to attend up to 10 GP appointments to get a menopause diagnosis, first-of-its-kind research has found. The UK’s largest ever polling of perimenopausal and menopausal women, ...